RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
-23.86%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$3.2B
AUM Growth
+$3.2B
(-27%)
Cap. Flow
-$1.25M
Cap. Flow
% of AUM
-0.04%
Top 10 Holdings %
Top 10 Hldgs %
52.42%
Holding
74
New
3
Increased
14
Reduced
34
Closed
4
Top Buys
| 1 |
ONEM
1Life Healthcare, Inc. Common Stock
ONEM
|
$37.7M |
| 2 |
Tandem Diabetes Care
TNDM
|
$31.5M |
| 3 |
Centene
CNC
|
$24.2M |
| 4 |
RAPT Therapeutics
RAPT
|
$16.5M |
| 5 |
GRTS
Gritstone bio, Inc. Common Stock
GRTS
|
$14.2M |
Top Sells
| 1 |
ICU Medical
ICUI
|
$27.4M |
| 2 |
Genmab
GMAB
|
$26.2M |
| 3 |
UnitedHealth
UNH
|
$26M |
| 4 |
ZGNX
Zogenix, Inc.
ZGNX
|
$16.2M |
| 5 |
Elevance Health
ELV
|
$13.3M |
Sector Composition
| 1 | Healthcare | 94.94% |
| 2 | Consumer Staples | 2.8% |
| 3 | Industrials | 1.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONEM
26
DELISTED
1Life Healthcare, Inc. Common Stock
ONEM
| $37.7M | 1.18% |
+3,404,835
| New | +$37.7M |
|
|
OSH
27
DELISTED
Oak Street Health, Inc.
OSH
| $32.4M | 1.01% |
1,203,619
| – | – |
|
|
28
Tandem Diabetes Care
TNDM
$833M
| $31.5M | 0.98% |
+271,218
| New | +$31.5M |
|
|
SLGC
29
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $31.3M | 0.98% |
3,906,770
-236,000
| -6% | -$1.89M |
|
30
Scholar Rock
SRRK
$3.28B
| $31M | 0.97% |
2,407,326
-40,600
| -2% | -$523K |
|
|
NVTA
31
DELISTED
Invitae Corporation
NVTA
| $30.3M | 0.95% |
3,805,403
| – | – |
|
|
NVRO
32
DELISTED
NEVRO CORP.
NVRO
| $29.7M | 0.93% |
411,017
+140,901
| +52% | +$10.2M |
|
|
GRTS
33
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $28.3M | 0.88% |
6,871,738
+3,442,567
| +100% | +$14.2M |
|
|
34
UnitedHealth
UNH
$277B
| $27.3M | 0.85% |
53,445
-51,043
| -49% | -$26M |
|
35
Prothena Corp
PRTA
$446M
| $26.9M | 0.84% |
736,175
-29,500
| -4% | -$1.08M |
|
|
ISEE
36
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $25M | 0.78% |
1,485,800
-14,200
| -0.9% | -$239K |
|
37
Shattuck Labs
STTK
$60.8M
| $23.9M | 0.75% |
5,619,914
| – | – |
|
38
Stevanato
STVN
$6.44B
| $23.1M | 0.72% |
1,150,225
-20,000
| -2% | -$402K |
|
39
Akero Therapeutics
AKRO
$3.61B
| $22.7M | 0.71% |
1,602,285
| – | – |
|
40
Pliant Therapeutics
PLRX
$103M
| $21.6M | 0.67% |
3,080,801
-2,700
| -0.1% | -$18.9K |
|
|
41
ICU Medical
ICUI
$3.04B
| $21.6M | 0.67% |
96,869
-123,057
| -56% | -$27.4M |
|
42
Entrada Therapeutics
TRDA
$202M
| $18.4M | 0.57% |
1,954,419
-1
| -0% | -$9 |
|
43
Bioventus
BVS
$472M
| $18.3M | 0.57% |
1,296,739
-28,400
| -2% | -$400K |
|
44
Nuvation Bio
NUVB
$1.04B
| $18.3M | 0.57% |
3,471,709
-199,300
| -5% | -$1.05M |
|
45
Jazz Pharmaceuticals
JAZZ
$7.94B
| $17.9M | 0.56% |
114,764
+16,700
| +17% | +$2.6M |
|
46
The Oncology Institute
TOI
$302M
| $17.2M | 0.54% |
2,414,432
-85,568
| -3% | -$610K |
|
|
47
RAPT Therapeutics
RAPT
$191M
| $16.5M | 0.51% |
+748,677
| New | +$16.5M |
|
|
ALLK
48
DELISTED
Allakos
ALLK
| $14.6M | 0.46% |
2,559,975
+482,100
| +23% | +$2.75M |
|
49
Zymeworks
ZYME
$1.06B
| $13.8M | 0.43% |
2,114,197
+1,239,800
| +142% | +$8.12M |
|
50
ALX Oncology
ALXO
$54.1M
| $13.1M | 0.41% |
772,397
-9,700
| -1% | -$164K |
|